Literature DB >> 87128

Late onset systemic lupus erythematosus.

S B Baker, J R Rovira, E W Campion, J A Mills.   

Abstract

This study describes the clinical and laboratory features and the natural history of 31 patients with late onset (in the sixth decade or later) systemic lupus erythematosus (SLE). Patients with late onset SLE constitute a distinct subset of the general lupus population that accounts for approximately 12 per cent of the cases. Advanced age modifies the expression of SLE in terms of clinical presentation (pleuritis and/or pericarditis are the most common presenting manifestations) and pattern of organ involvement (pulmonary abnormalities are more common, whereas lymphadenopathy, Raynaud's phenomenon, neuropsychiatric disease, alopecia and skin rash are less common). Because SLE is not usually considered to be a disease that affects the elderly, and because the pattern of SLE in the older age group may differ substantially from the seen in younger patients, there is often a delay in diagnosis (median of 10 months, with a delay of over one year in 32 per cent of patients). In light of the high incidence of steroid complications in older patients (40 per cent in our series), and because these patients with SLE have a relatively good prognosis (five year survival of 92.3 per cent; nine year survival of 83.1 per cent), therapy should be more conservative in late onset SLE.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87128     DOI: 10.1016/0002-9343(79)91109-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  26 in total

1.  Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients.

Authors:  Zheng Tang; Dongmei Chen; Shengmei Yang; Haitao Zhang; Weixin Hu; Zhihong Liu; Leishi Li
Journal:  Rheumatol Int       Date:  2010-06-10       Impact factor: 2.631

Review 2.  Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.

Authors:  Laurent Arnaud; Alexis Mathian; Jacques Boddaert; Zahir Amoura
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

3.  Comparison of clinical, serological, and prognostic differences among juvenile-, adult-, and late-onset lupus nephritis in Korean patients.

Authors:  Ji-Hyoun Kang; Dong-Jin Park; Kyung-Eun Lee; Ji Shin Lee; Yoo-Duk Choi; Shin-Seok Lee
Journal:  Clin Rheumatol       Date:  2017-04-25       Impact factor: 2.980

4.  New-onset systemic lupus erythematosus in a long-term hemodialysis patient with acute pleuritis and pneumonitis.

Authors:  Hiroto Hiyamuta; Shunsuke Yamada; Ryusuke Yotsueda; Shoko Hasegawa; Toshiaki Nakano; Masatomo Taniguchi; Hiroshi Tsukamoto; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  CEN Case Rep       Date:  2014-11-07

Review 5.  Systemic lupus erythematosus: treatment and prognosis.

Authors:  G R Hughes
Journal:  Br Med J       Date:  1979-10-27

Review 6.  Systemic lupus erythematosus clinical issues.

Authors:  M B Stevens
Journal:  Springer Semin Immunopathol       Date:  1986

7.  Prevalence and incidence of systemic lupus erythematosus in South Korea.

Authors:  Jee-Seon Shim; Yoon-Kyoung Sung; Young Bin Joo; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

8.  Organic brain syndrome with psychosis as an initial manifestation of systemic lupus erythematosus in an elderly woman.

Authors:  M E Mavrikakis; L G Antoniades; J B Germanides; D Sotou; A Rassidakis
Journal:  Ann Rheum Dis       Date:  1992-01       Impact factor: 19.103

9.  Systemic lupus erythematosus in the elderly: clinical and immunological characteristics.

Authors:  J Font; L Pallarés; R Cervera; A López-Soto; M Navarro; X Bosch; M Ingelmo
Journal:  Ann Rheum Dis       Date:  1991-10       Impact factor: 19.103

10.  The actual survival rate in systemic lupus erythematosus: study of a 1976 cohort.

Authors:  M Breban; O Meyer; P Bourgeois; E Palazzo; M F Kahn
Journal:  Clin Rheumatol       Date:  1991-09       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.